Frequent p53 mutation in relapsed acute lymphoblastic leukemia with cytogenetic instability: A longitudinal analysis

Anticancer Research

Volumn 18, Issue 2 B, 1998, Pages 1273-1278

  Tang, Jih Luh ^a   Tien, Hwei Fang ^a   Lin, Ming Tseh ^a   Chen, Pei Jer ^b   Chen, Yao Chang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Acute lymphoblastic leukemia; Cytogenetic instability; p53 gene; Relapse; Single strand conformation polymorphism

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CYTOGENETICS; DNA REPAIR; FEMALE; GENE MUTATION; HUMAN; LONGITUDINAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 84984550338     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Chang F, Syrjanen S, Syrjanen K: Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol 13: 1009-1022, 1995.
2. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
3. Carson DA, Lois A: Cancer progression and p53. Lancet 346: 1009-1011, 1995.
4. Prokocimer M, Rotter V: Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood 84: 2391-2411, 1994.
5. Wattel E, Preudhomme C, Hecquet B, Vanrumbeke M, Quesnel B, Dervite I, Morel P, Fenaux P: p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood 84: 3148-3157, 1994.
6. Bates S, Vousden KH: p53 in signaling checkpoint arrest or apoptosis. Curr Opin Genet Dev 6: 12-19
7. Lowe SW, Bodies S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T: p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810, 1994.
8. Jonveaux P, Berger R: Infrequent mutations in the P53 gene in primary human T-cell acute lymphoblastic leukemia. Leukemia 5: 839-840, 1991
9. Fenaux P, Jonveaux P, Quiquandon I, Preudhomme C, Lai JL, Vanrumbeke M, Loucheux-Lefebvre MH, Bauters F, Berger R, Kerckaert JP: Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases. Leukemia 6: 42-46, 1992.
10. Wada M, Bartram CR, Nakamura H, Hackiya M, Chen D-L, Borenstein J, Miller CW, Ludwig L, Hansen-Hagge TE, Ludwig WD, Reiter A, Mizoguchi H, Koeffler HP: Analysis of p53 mutations in a large series of lymphoid malignancies of childhood. Blood 82: 3163-3169, 1993.
11. Hsiao MH, Yu AL, Yeargin J, Ku D, Haas M: Nonhereditary p53 mutations in T-cell acute lymphoblastic leukemia are associated with the relapse phase. Blood 83: 2922-2930, 1994.
12. Tsai T, Davalath S, Rankin C, Radich JP, Head D, Appelbaum FR, Boldt DH: Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies. Leukemia 10: 1901-1910, 1996.
13. Diccianni MB, Yu J, Hsiao M, Mukherjee S, Shao LE, Yu AL: Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia. Blood 84:3105-3112, 1994.
14. Preudhomme C, Dervite I, Wattel E, Vanrumbeke M, Flactif M, Lai JL, Hecquet B, Coppin MC, Nelken B, Gosselin B Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases. J Clin Oncol 13: 812-820, 1995.
15. Kawamura M, Kikuchi A, Kobayashi S, Hanada R, Yamamoto K, Horibe K, Shikano T, Ueda K, Hayashi K, Sekiya T: Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia. Blood 85: 2546-2552, 1995.
16. Lanza C, Gaidano G, Cimino G, Pastore C, Nomdedeu J, Volpe G, Vivenza C, Parvis G, Mazza U, Basso G, Madon E, Coco FL, Saglio G: Distribution of TP53 mutations among acute leukemias with MLL rearrangements. Genes Chromosomes Cancer 15: 48-53, 1996.
17. Goker E, Waltham M, Kheradpour A, Trippett T, Mazumdar M, Elisseyeff Y, Schnieders B, Steinherz P, Tan C, Berman E: Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations. Blood 86: 677-684, 1995.
18. Marks DI, Kurz BW, Link MP, Ng E, Shuster JJ, Lauer SJ, Brodsky I, Haines DS: High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis. Blood 87: 1155-1161, 1997.
19. Marks DI, Kurz BW, Link MP, Ng E, Shuster JJ, Lauer SJ, Carroll D, Brodsky I, Haines DS: Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia. J Clin Oncol 15: 1158-1162, 1997.
20. Tien HF, Wang CH, Lee FY, Liu MC, Chuang SM, Chen YC, Shen MC, Lin DT, Lin KH, Chu WM: Cytogenetic study of acute lymphoblastic leukemia and its correlation with immunophenotype and genotype. Cancer Genet Cytogenet 59: 191-198, 1992.
21. Estey E, Keating MJ, Pierce S, Stass S: Changes in karyotype between diagnosis and first relapse in acute myelogenous leukemia. Leukemia 9: 972-976, 1995.
22. Tang JL, Yeh SH, Chen PJ, Lin MT, Tien HF, Chen YC (1992) Inactivation of the retinoblastoma gene in acute myelogenous leukemia. Br J Haematol 82: 502-507
23. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS (1991) 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 19: 4008
24. Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874-879
25. Wada H, Minoru A, Nakazawa S, Itoh H, Kobayashi Y, Inoue T, Fukumuro K, Chan LC, Sugjta K, Hanada R, Akuta N, Kobayashi N, Mizutani S (1994) Clonal expansion of p53 mutant cells in leukemia progression in vitro. Leukemia 8: 53-59.
26. Nakai H, Misawa S: Chromosome 17 abnormalities and inactivation of the p53 gene in chronic myeloid leukemia and their prognostic significance. Leuk Lymphoma 19: 213-21, 1995.
27. Seeker-Walker LM, Alimena G, Bloomfield CD, Kaneko Y, Whang-Peng J, Arthur DC, de la Chapelle A, Reeves BR, Rowley JD, Lawler SD: Cytogenetic studies of 21 patients with acute lymphoblastic leukemia in relapse. Cancer Genet Cytogenet 40: 163-169, 1989.
28. Heerema NA, Palmer CG, Weetman R, Bertolone S: Cytogenetic analysis in relapsed childhood acute lymphoblastic leukemia. Leukemia 6: 185-192, 1992.
29. Chucrallah AE, Stass SA, Huh YO, Albitar M, Kantarjian HM: Adult acute lymphoblastic leukemia at relapse. Cytogenetic, immunophenotypic, and molecular changes. Cancer 76: 985-991, 1995.
30. Coleman WB, Tsongalis GJ: Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformation. Clin Chem 41: 644-657, 1995.
31. Smith ML, Fornace AJ: Genomic instability and the role of p53 mutations in cancer cells. Curr Opin Oncol 7: 69-75, 1995.
32. Almasan A, Linke SP, Paulson TG, Huang LC, Wahl GM: Genetic instability as a consequence of inappropriate entry into and progression through S-phase. Cancer Metastasis Rev 14: 59-73, 1995.
33. Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly JM, Wang Z, Friedberg EC, Evans MK, Taffe BG, Bohr VA, Weeda G, Hoeijmakers JHJ, Forrester K, Harris CC (1995) p53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Genet 10: 188-195
34. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF: Abnormal centrosome amplification in the absence of p53. Science 271: 1744-1747, 1996.
35. Lobe LA: Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 54: 5059-5063, 1994.
36. Fishel R, Kolodner RD: Identification of mismatch repair genes and their role in the development of cancer. Curr Op Genet Develop 5: 382-395, 1995.
37. Ben-Yehuda D, Krichevsky S, Caspi O, Rund D, Polliack A, Abeliovich D, Zelig O, Yahalom V, Paltiel O, Or R, Peretz T, Ben-Neriah S, Yehuda O, Rachmilewitz EA: Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood 88: 4296-4303, 1996.
38. Baccichet A, Benachenhou N, Couture F, Leclerc JM, Sinnett D: Microsatellite instability in childhood T cell acute lymphoblastic leukemia. Leukemia 11: 797-802, 1997.
39. Cave H, Guidal C, Elion J, Vilmer E, Grandchamp B: A low rate of loss of heterozygosity is found at many different loci in childhood B-lineage acute lymphocytic leukemia. Leukemia 10: 1486-1491, 1996.
40. Takeuchi S, Seriu T, Tasaka T, Koike M, Cho SK, Park S, Slater J, Mufti I, Hatta Y, Miyoshi I, Bartram CR, Koeffler HP Microsatellite instability and other molecular abnormalities in childhood acute lymphoblastic leukaemia. Br J Haematol 98: 134-139, 1997.
41. Reitmair AH, Schmits R, Ewel A, Bapat B, Redston M, Mitri A, Waterhouse P, Mittrucker HW, Wakeham A, Liu B: MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nature Genet 11: 64-70, 1995.
42. Hangaishi A, Ogawa S, Mitani K, Hosoya N, Chiba S, Yazaki Y, Hirai H: Mutations and loss of expression of a mismatch repair gene, hMLH1, in leukemia and lymphoma cell lines. Blood 89: 1740-1747, 1997.